{"entity":{"type":"insider","cik":"0001791917","url":"/insider/0001791917","json_url":"/insider/0001791917.json","name":"BIOS Fund III, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":9,"first":"2022-09-29","last":"2025-06-30","span_basis":"filed_date"},"name_variants":[{"name":"BIOS Fund III, LP","source":"filing","n_filings":9,"first_seen":"2022-09-29","last_seen":"2025-06-30"}],"transactions":[{"id":4986683,"accession":"0001104659-25-063991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-063991","line_url":"/filing/0001104659-25-063991#line-1","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"Bios Actuate Co-Invest III, LP; BIOS Fund III, LP; BIOS Fund III QP, LP; BIOS Equity Partners III, LP; BIOS Capital Management, LP; BIOS Actuate Co-Invest II, LP; BIOS Advisors GP, LLC; BIOS Actuate Co-Invest I, LP; BIOS Fund III NT, LP; Fletcher Aaron G.L.","owner_display_name":"Bios Actuate Co-Invest III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71428.0,"shares_display":"71,428","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":499996.0,"total_display":"499,996.00","total_whole":"499,996","shares_owned_after":196428.0,"shares_owned_after_display":"196,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-06-30","scope":"insider"},{"id":9223891,"accession":"0001104659-24-091371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-091371","line_url":"/filing/0001104659-24-091371","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"BIOS Actuate Co-Invest I, LP; BIOS Actuate Co-Invest II, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Equity Partners III, LP; BIOS Fund III NT, LP; BIOS Fund III QP, LP; BIOS Fund III, LP; Bios Actuate Co-Invest III, LP; Fletcher Aaron G.L.","owner_display_name":"BIOS Actuate Co-Invest I, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":199992.0,"total_display":"199,992.00","total_whole":"199,992","shares_owned_after":980433.0,"shares_owned_after_display":"980,433","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-20","scope":"insider","n_lines":3},{"id":2837581,"accession":"0001104659-24-089822","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001104659-24-089822","line_url":"/filing/0001104659-24-089822","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"BIOS Fund III, LP; BIOS Fund III QP, LP; BIOS Equity Partners III, LP; Bios Actuate Co-Invest III, LP; BIOS Fund III NT, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Actuate Co-Invest I, LP; Fletcher Aaron G.L.; BIOS Actuate Co-Invest II, LP","owner_display_name":"BIOS Fund III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":224991.0,"total_display":"224,991.00","total_whole":"224,991","shares_owned_after":980433.0,"shares_owned_after_display":"980,433","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider","n_lines":3},{"id":2837570,"accession":"0001104659-24-089822","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001104659-24-089822","line_url":"/filing/0001104659-24-089822","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"BIOS Fund III, LP; BIOS Fund III QP, LP; BIOS Equity Partners III, LP; Bios Actuate Co-Invest III, LP; BIOS Fund III NT, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Actuate Co-Invest I, LP; Fletcher Aaron G.L.; BIOS Actuate Co-Invest II, LP","owner_display_name":"BIOS Fund III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":1259427.0,"shares_owned_after_display":"1,259,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider","n_lines":2},{"id":7844182,"accession":"0001104659-23-074424","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-21","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Convertible Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":509141.0,"shares_display":"509,141","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844179,"accession":"0001104659-23-074424","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-20","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Convertible Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82223.0,"shares_display":"82,223","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844177,"accession":"0001104659-23-074424","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-19","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Convertible Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77953.0,"shares_display":"77,953","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844174,"accession":"0001104659-23-074424","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-18","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1291258.0,"shares_display":"1,291,258","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1291258.0,"shares_owned_after_display":"1,291,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844171,"accession":"0001104659-23-074424","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-17","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":456412.0,"shares_display":"456,412","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2282060.0,"total_display":"2,282,060.00","total_whole":"2,282,060","shares_owned_after":1747670.0,"shares_owned_after_display":"1,747,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844168,"accession":"0001104659-23-074424","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-16","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":208531.0,"shares_display":"208,531","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":208531.0,"shares_owned_after_display":"208,531","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844165,"accession":"0001104659-23-074424","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-15","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197701.0,"shares_display":"197,701","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":197701.0,"shares_owned_after_display":"197,701","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844163,"accession":"0001104659-23-074424","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-14","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73708.0,"shares_display":"73,708","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":368540.0,"total_display":"368,540.00","total_whole":"368,540","shares_owned_after":282239.0,"shares_owned_after_display":"282,239","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7844160,"accession":"0001104659-23-074424","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001104659-23-074424","line_url":"/filing/0001104659-23-074424#line-13","is_derivative":false,"issuer_cik":"0001701478","issuer_name":"Azitra Inc","issuer_ticker":"AZTR","issuer_name_source":null,"issuer_url":"/issuer/0001701478","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; Fletcher Aaron G.L.; BIOS Equity Partners III, LP; BIOS Fund III, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Azitra Co-Invest I, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69880.0,"shares_display":"69,880","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":349400.0,"total_display":"349,400.00","total_whole":"349,400","shares_owned_after":267581.0,"shares_owned_after_display":"267,581","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":6476643,"accession":"0001104659-22-126432","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-126432","line_url":"/filing/0001104659-22-126432","is_derivative":false,"issuer_cik":"0001714576","issuer_name":"IN8BIO, INC.","issuer_ticker":"INAB","issuer_name_source":null,"issuer_url":"/issuer/0001714576","owner_cik":null,"owner_name":"Fletcher Aaron G.L.; BIOS Capital Management, LP; BIOS Incysus Co-Invest I, LP; BIOS Advisors GP, LLC; BIOS Fund II, LP; BIOS Fund II NT, LP; BIOS Fund III QP, LP; BIOS Fund II QP, LP; BIOS Fund III NT, LP; BIOS Fund III, LP","owner_display_name":"Fletcher Aaron G.L.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75001.0,"shares_display":"75,001","price_per_share":2.4788,"price_display":"2.48","price_state":"stated","total_value":185912.4788,"total_display":"185,912.48","total_whole":"185,912","shares_owned_after":3727597.0,"shares_owned_after_display":"3,727,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider","n_lines":3},{"id":6771086,"accession":"0001104659-22-122622","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-122622","line_url":"/filing/0001104659-22-122622","is_derivative":false,"issuer_cik":"0001455365","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001455365","owner_cik":null,"owner_name":"BIOS Memory SPV II, LP; Cavu Advisors, LLC; BIOS Fund II NT, LP; BIOS Fund III, LP; Cavu Management, LP; BIOS Equity Partners III, LP; BIOS Fund III QP, LP; BIOS Fund III NT, LP; Kreis Leslie W.","owner_display_name":"BIOS Memory SPV II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16064.0,"shares_display":"16,064","price_per_share":2.6497,"price_display":"2.65","price_state":"stated","total_value":42564.7808,"total_display":"42,564.78","total_whole":"42,565","shares_owned_after":2021906.0,"shares_owned_after_display":"2,021,906","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-29","scope":"insider","n_lines":3},{"id":6269279,"accession":"0001104659-22-119719","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-119719","line_url":"/filing/0001104659-22-119719","is_derivative":false,"issuer_cik":"0001455365","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001455365","owner_cik":null,"owner_name":"BIOS Equity Partners III, LP; BIOS Fund III QP, LP; BIOS Fund II NT, LP; BIOS Fund III, LP; Kreis Leslie W.; Cavu Management, LP; BIOS Memory SPV II, LP; Cavu Advisors, LLC; BIOS Fund III NT, LP","owner_display_name":"BIOS Equity Partners III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71000.0,"shares_display":"71,000","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":99400.0,"total_display":"99,400.00","total_whole":"99,400","shares_owned_after":2009686.0,"shares_owned_after_display":"2,009,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider","n_lines":3},{"id":6269270,"accession":"0001104659-22-119339","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-119339","line_url":"/filing/0001104659-22-119339","is_derivative":false,"issuer_cik":"0001455365","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001455365","owner_cik":null,"owner_name":"Kreis Leslie W.; Cavu Advisors, LLC; BIOS Equity Partners III, LP; BIOS Fund III QP, LP; BIOS Fund II NT, LP; BIOS Fund III, LP; BIOS Memory SPV II, LP; BIOS Fund III NT, LP; Cavu Management, LP","owner_display_name":"Kreis Leslie W.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":1955677.0,"shares_owned_after_display":"1,955,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-16","scope":"insider","n_lines":3},{"id":6462121,"accession":"0001104659-22-103860","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-103860","line_url":"/filing/0001104659-22-103860","is_derivative":false,"issuer_cik":"0001714576","issuer_name":"IN8BIO, INC.","issuer_ticker":"INAB","issuer_name_source":null,"issuer_url":"/issuer/0001714576","owner_cik":null,"owner_name":"BIOS Fund III QP, LP; BIOS Incysus Co-Invest I, LP; BIOS Fund III, LP; BIOS Fund II NT, LP; BIOS Capital Management, LP; BIOS Advisors GP, LLC; Fletcher Aaron G.L.; BIOS Fund II, LP; BIOS Fund II QP, LP; BIOS Fund III NT, LP","owner_display_name":"BIOS Fund III QP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.0214,"price_display":"2.02","price_state":"stated","total_value":50535.0,"total_display":"50,535.00","total_whole":"50,535","shares_owned_after":3670545.0,"shares_owned_after_display":"3,670,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-29","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652935","name":"ACTUATE THERAPEUTICS, INC.","url":"/issuer/0001652935","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2024-08-14","last_seen":"2025-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001701478","name":"Azitra Inc","url":"/issuer/0001701478","role":"Ten percent owner","n_filings":1,"first_seen":"2023-06-23","last_seen":"2023-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001740279","name":"IN8BIO, INC.","url":"/issuer/0001740279","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2022-09-29","last_seen":"2022-12-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001455365","name":"COGNITION THERAPEUTICS INC","url":"/issuer/0001455365","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2022-11-16","last_seen":"2022-11-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001791917","retrieved_at":"2026-08-25T00:00:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}